Health

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

* Polytaxel, a novel pain-free anticancer drug, may not require break periods * A new standard of care, more convenient than docetaxel, is suggested * Hyundai Bioscience to enter clinical trial on pancreatic cancer in Australia * Patient-centered chemotherapy to enable outpatients to live nor...

2022-11-25 21:00 12313

Concord Medical Schedules 2022 Annual Meeting of Shareholders

BEIJING, Nov. 25, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensi...

2022-11-25 19:30 11853

Peijia Medical Limited and inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System

SUZHOU, China, Nov. 25, 2022 /PRNewswire/ -- inQB8 Medical Technologies, LLC (inQB8), in Partnership with Peijia Medical Limited (Peijia, (9996.HK)), announced today that it has successfully implanted the MonarQ Transcatheter Tricuspid Valve in a 75-year-old female suffering from severe torrentia...

2022-11-25 16:00 2587

Edenlux launches AI-based service "Otus Plus Eye Health Care Report"

SEOUL, South Korea, Nov. 24, 2022 /PRNewswire/ -- On November 24, Edenlux (CEO Sy Park) announced that it will provide an artificial intelligence (AI) eye health management report for the users of Otus Plus, its flagship product.

2022-11-24 22:00 4317

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

- Obtained marketing approval on the 23rd (local time) from the Therapeutic Goods Administration (TGA) ofAustralia for the indication of glabellar lines - First shipment and local launch planned for Q1 2023...Plans to cooperate with major chain clinics and key opinion leaders SEOUL, South Korea,...

2022-11-24 22:00 5212

Mabwell Announces the U.S. FDA approval of 9MW3011 (FIC) for IND

SHANGHAI, Nov. 24, 2022 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that its clinical trial application for 9MW3011 Injection used in patients with polycythemia vera was formally approved by the United States Food...

2022-11-24 21:00 4239

Rokid and Eyedaptic Launch EYE5 to Help AMD Patients Enhance Their Vision

HANGZHOU, China, Nov. 23, 2022 /PRNewswire/ -- Recently, Rokid, an augmented reality glasses manufacturer,  partnered with Eyedaptic to unveil the all-new EYE5 smart glasses at the American Academy of Optometry 2022 Annual Meeting and Expo. The latest model brings wearability to a whole new level...

2022-11-24 12:20 2516

Korea Ginseng Corp.: As an adaptogenic herb, Korean red ginseng boosts the human immune response

*  KORESELECT Immune receives the 2022 Taste For Life Immunity Essential award CERRITOS, Calif., Nov. 23, 2022 /PRNewswire/ -- Korean Ginseng Corp., the world's number one Korean red ginseng brand, is highlighting Korean red ginseng as another way to stay healthy.

2022-11-23 23:00 3604

AnchorDx Enrolls the First Patient For Its UriFind® Bladder Cancer Assay Clinical Trial in the U.S.

GUANGZHOU, China, Nov. 23, 2022 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer early detection solutions, announced the first patient enrollment for the UriFind® bladder cancer assay clinical trial in the U.S., an over 1,000-patient multi-center, prospective testing of the assay in...

2022-11-23 22:00 3705

Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Nov. 23, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment o...

2022-11-23 21:00 4029

J INTS BIO, M.D Anderson Cancer Center joint development - oral HSP90 inhibitor 'JIN-001', presentation of preclinical assessment at 2022 SNO Annual Meeting

SEOUL, South Korea, Nov. 23, 2022 /PRNewswire/ -- J INTS BIO announced that the preclinical assessment of JIN-001 or MPT0B640, a novel, orally administered 2nd generation HSP90 (heat shock protein 90) inhibitor, was presented during the 2022 edition of the Society for Neuro-Oncology Conference, h...

2022-11-23 15:18 1947

Jiangsu Traditional Chinese Medicine International Exchange Conference kicked off in Nanjing

NANJING, China, Nov. 23, 2022 /PRNewswire/ -- On November 21st, the "Jiangsu Traditional Chinese Medicine International Exchange Conference" jointly sponsored by the Foreign Affairs Office of Jiangsu Provincial People's Government and Jiangsu Health Commission kicked off inNanjing. The theme of t...

2022-11-23 14:19 2194

PHISKIN Rolls Out Upgrade of Its One-stop High-end Medical Service System

SHANGHAI, Nov. 22, 2022 /PRNewswire/ -- PHISKIN, a Chinese aesthetic medicine clinics brand, has announced a new enhancement to its one-stop high-end medical service system as part of the expansion of its healthcare business. The firm was founded inShanghai in 2012 and pioneered the era of aesthe...

2022-11-22 22:35 3549

Oral Care Brand Bitvae Receives American Dental Association Certificate for its D2 and S2 Smart Electric Toothbrushes

The brand's connected technology and intuitive product features help its users monitor and improve their oral care routine and that of their families. NEW YORK, Nov. 22, 2022 /PRNewswire/ -- Bitvae , a b...

2022-11-22 22:30 3540

Luvme Cares for Women's Health in Alopecia & Breast Cancer Themed Charity Events

NEW YORK, Nov. 22, 2022 /PRNewswire/ -- Luvme Hair , a leading brand in the wig industry inNorth America, invited her customers to participate in a series of events across her social media communities to raise awareness for alopecia, illness-induced hair loss, and bre...

2022-11-22 21:23 3799

Illuccix® Available on High Activity Gallium Generator Technology to Meet High Demand

INDIANAPOLIS, Nov. 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection) with up to 50mCi for radiolabeling is available for use on 100mCi (millicurie) gallium generators, an ...

2022-11-22 20:00 2292

IND approval from the US FDA for theranostic SAR-Bombesin trial in prostate cancer

SYDNEY, Nov. 21, 2022 /PRNewswire/ --  Highlights * Clarity's fifth successful Investigational New Drug (IND) application with theUnited States Food and Drug Administration (US FDA), opening up therapeutic applications for SAR-Bombesin * A total of six products with both the diagnostic and t...

2022-11-21 22:04 3537

United Imaging Drives Forward Several Major Innovations in Multiple Imaging Modalities

The company's IPO and 20,000th global installation are followed by new technological innovations, in keeping with its commitments to the U.S. and other markets. HOUSTON, Nov. 21, 2022 /PRNewswire/ -- United Imaging, a global leader in producing advanced medical imaging and radiotherapy equipment...

2022-11-21 22:00 3476

Mintal Tracker Lets Users See Their Dreams - Again

AI-driven feature automatically generates an image of the user's dream by utilizing key words, enabling the ability to physically share their dreams SUNNYVALE, Calif., Nov. 21, 2022 /PRNewswire/ -- Mintal Tracker, a sleep tracking app driven by artificial intelligence (AI) technology that offers ...

2022-11-21 21:00 2377

Professor László Tabár Joins DetectedX as the Medical Director of Breast Cancer Imaging

DetectedX Bolsters Executive Team with Internationally Renowned Physician, Academic and Educator to Expand Breast Imaging Educational Content on the Company's Radiology Online Learning Platform SYDNEY, Nov. 21, 2022 /PRNewswire/ -- DetectedX, leaders in intelligent interactive educational techno...

2022-11-21 21:00 2243
1 ... 115116117118119120121 ... 273